Belbuca FDA Approval History
FDA Approved: Yes (First approved October 23, 2015)
Brand name: Belbuca
Generic name: buprenorphine hydrochloride
Dosage form: Buccal Film
Company: Endo Pharmaceuticals Inc.
Treatment for: Chronic Pain
Belbuca (buprenorphine) is a partial opioid agonist analgesic in a buccal film formulation for the management of chronic pain.
Development timeline for Belbuca
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.